DK0691849T3 - Osteoblastvækststimulerende præparat indeholdende PDGF og vitamin D - Google Patents

Osteoblastvækststimulerende præparat indeholdende PDGF og vitamin D

Info

Publication number
DK0691849T3
DK0691849T3 DK94911725T DK94911725T DK0691849T3 DK 0691849 T3 DK0691849 T3 DK 0691849T3 DK 94911725 T DK94911725 T DK 94911725T DK 94911725 T DK94911725 T DK 94911725T DK 0691849 T3 DK0691849 T3 DK 0691849T3
Authority
DK
Denmark
Prior art keywords
vitamin
preparation containing
growth stimulating
osteoblast growth
containing pdgf
Prior art date
Application number
DK94911725T
Other languages
English (en)
Inventor
Emma E Moore
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK0691849T3 publication Critical patent/DK0691849T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/135Platelet-derived growth factor [PDGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94911725T 1993-03-29 1994-03-29 Osteoblastvækststimulerende præparat indeholdende PDGF og vitamin D DK0691849T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3832593A 1993-03-29 1993-03-29
PCT/US1994/003331 WO1994022463A1 (en) 1993-03-29 1994-03-29 Oesteoblast growth stimulating compostion containing pdgf and vitamin d

Publications (1)

Publication Number Publication Date
DK0691849T3 true DK0691849T3 (da) 1999-12-13

Family

ID=21899306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911725T DK0691849T3 (da) 1993-03-29 1994-03-29 Osteoblastvækststimulerende præparat indeholdende PDGF og vitamin D

Country Status (14)

Country Link
US (1) US5533836A (da)
EP (1) EP0691849B1 (da)
JP (1) JP3699111B2 (da)
KR (1) KR960701648A (da)
CN (1) CN1104257C (da)
AT (1) ATE180674T1 (da)
AU (1) AU681879B2 (da)
CA (1) CA2159449C (da)
DE (1) DE69418865T2 (da)
DK (1) DK0691849T3 (da)
ES (1) ES2132399T3 (da)
GR (1) GR3030402T3 (da)
RU (1) RU2140282C1 (da)
WO (1) WO1994022463A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700289A (en) * 1995-10-20 1997-12-23 North Shore University Hospital Research Corporation Tissue-engineered bone repair using cultured periosteal cells
WO1997048694A1 (en) * 1996-06-20 1997-12-24 Board Of Regents, The University Of Texas System Compounds and methods for providing pharmacologically active preparations and uses thereof
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6042855A (en) * 1997-06-27 2000-03-28 United States Of America (Usda) Use of vitamin D, its metabolites and analogs to improve tenderness of meat and meat products
EP1043963A4 (en) * 1997-12-31 2001-02-07 Depuy Orthopaedics Inc OSTEOPONTIN-BASED COMPOSITION TO INCREASE BONE FORMATION
US6551355B1 (en) 1998-08-14 2003-04-22 Cambridge Scientific, Inc. Tissue transplant coated with biocompatible biodegradable polymer
US6663870B2 (en) * 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
WO2001032197A2 (en) * 1999-11-02 2001-05-10 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2007061889A2 (en) * 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
CA2656278C (en) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
ES2422259T3 (es) * 2008-02-07 2013-09-10 Biomimetic Therapeutics Inc Composiciones para la osteogénesis por distracción
BE1018748A3 (fr) * 2008-05-07 2011-08-02 Bone Therapeutics Sa Nouvelles cellules souches mesenchymateuses et cellules osteogeniques .
EP2327427A4 (en) * 2008-08-19 2014-01-22 Univ Osaka CELL PREPARATION FOR BONE WEAVER AGENCY
KR20110067035A (ko) 2008-09-09 2011-06-20 바이오미메틱 세라퓨틱스, 인크. 건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
EP2823787B1 (en) * 2012-02-01 2019-01-09 Organ Technologies, Inc. Dental implant and method for producing same
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
US4350687A (en) * 1980-02-10 1982-09-21 Research Corporation Platelet derived cell growth factor
CA1322714C (en) * 1986-11-14 1993-10-05 Harry N. Antoniades Wound healing and bone regeneration
DE3785758T2 (de) * 1986-11-14 1993-08-05 Harvard College Wundheilung und knochenregeneration.
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
CA2110410C (en) * 1991-06-05 1997-04-15 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US5129691A (en) * 1991-08-20 1992-07-14 Mcfarlen Jonn Gate latch control device

Also Published As

Publication number Publication date
DE69418865D1 (de) 1999-07-08
RU2140282C1 (ru) 1999-10-27
ATE180674T1 (de) 1999-06-15
CA2159449A1 (en) 1994-10-13
GR3030402T3 (en) 1999-09-30
AU6417194A (en) 1994-10-24
JPH08508499A (ja) 1996-09-10
DE69418865T2 (de) 2000-02-17
WO1994022463A1 (en) 1994-10-13
KR960701648A (ko) 1996-03-28
CN1121693A (zh) 1996-05-01
EP0691849B1 (en) 1999-06-02
US5533836A (en) 1996-07-09
CA2159449C (en) 1999-09-14
ES2132399T3 (es) 1999-08-16
JP3699111B2 (ja) 2005-09-28
AU681879B2 (en) 1997-09-11
CN1104257C (zh) 2003-04-02
EP0691849A1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
GR3030402T3 (en) Oesteoblast growth stimulating compostion containing pdgf and vitamin d
DE69028535D1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
EP0339607A3 (en) Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant
NO921875D0 (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
IL107207A0 (en) Sustained release pharmaceutical compositions
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
FI910113A7 (fi) Kudossiirrekoostumus ja menetelmä
RU94045951A (ru) Покровный материал и способ его получения, имплантант для биомедицинского использования
AU4381793A (en) Gel composition for implant prosthesis and method of use
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
SE9901973L (sv) Implantat för applicering i ben och förfarande och användning vid sådant implantat
AT338429B (de) Zur verankerung von implantaten und gelenkendoprothesen im knochen dienende mischung
IT8712594A0 (it) Perno autofilettante per l impianto di protesi dentali
NL7601628A (nl) Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese.
AT388096B (de) Implantat zur befestigung von zahnprothesen
EP0441639A3 (en) Instrument for the application of controlled mechanical loads to tissues in sterile culture
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
AU6735687A (en) Porous hydroxyl apatite derived from lime-encrusting algae
FI895910A7 (fi) Antiseptiset koostumukset ja menetelmä niiden valmistamiseksi
DE122005000001I2 (de) Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE3681429D1 (de) Knochenzement.
DE60023157D1 (de) Phospholipid-beschichtete implantate
IT1249004B (it) Metodo e composizione per la stimolazione della crescita di vegetali
EP0347932A3 (en) Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht